Orphanet: Simple search
x

Search for a diagnostic test

* (*) mandatory field

119 Result(s)

Filter by

Speciality(ies)/objective(s)

Technique(s)

Purpose(s)

Quality management

Country(ies)

Reset
Sort by

Caption : Accreditation =Accreditation ;

FRANCE

OCCITANIE
MONTPELLIER

Accreditation Diagnosis of malignant hemopathies
CHU de Montpellier - Hôpital Saint-Eloi
Purpose(s) : Somatic genetics
Specialty(ies) : Cytogenetics

More information
GERMANY

Nordrhein-Westfalen
DORTMUND

Accreditation Diagnosis of myeloproliferative disorders (JAK2(V617F), MPL, TET2 genes)
Medizinisches Versorgungszentrum (MVZ) Dr. Eberhard und Partner
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Niedersachsen
HANNOVER

Accreditation Diagnosis of chronic myeloproliferative disorders (JAK2 gene: V617F)
Medizinische Hochschule Hannover
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing

More information
GERMANY

Rheinland-Pfalz
INGELHEIM AM RHEIN

Accreditation Diagnosis of chronic myeloproliferative disorders (JAK2 gene: mutation V617F)
Bioscientia Institut für Medizinische Diagnostik GmbH
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

More information
GREECE

ATTIKI
ATHENS

Accreditation Molecular diagnosis of myeloproliferative diseases : search for V617F mutation in JAK2 gene by ARMS-PCR
BioAnalytica-GenoType SA
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Technique(s) : PCR based techniques

More information
GERMANY

Bayern
MARTINSRIED

Accreditation Diagnosis of myeloproliferative disorders (JAK2 (exon 12, exon 14 (V617F)), MPL (exon 10), TET2 (exon 3-11) and PRV1 genes)
Zentrum für Humangenetik und Laboratoriumsdiagnostik (MVZ)
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
UNITED KINGDOM

South Yorkshire
SHEFFIELD

Accreditation Molecular diagnosis of chronic myeloproliferative diseases (JAK2: by mutation analysis for V617F)
Sheffield Children's NHS Foundation Trust
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

More information
UNITED KINGDOM

South Yorkshire
SHEFFIELD

Accreditation Molecular monitoring of donor chimerism post stem cell transplantation
Sheffield Children's NHS Foundation Trust
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

More information
GERMANY

Berlin
BERLIN

Accreditation Diagnosis of chronic myeloproliferative disease
Charité - Universitätsmedizin Berlin (CVK)
Purpose(s) : Somatic genetics
Specialty(ies) : Cytogenetics
Objective(s) : Detection of chromosome alterations large in size
Technique(s) : FISH

More information
GERMANY

Mecklenburg-Vorpommern
ROSTOCK

Accreditation Diagnosis of chronic myeloproliferative disorders (JAK2 gene: mutation V617F)
Diagenom GmbH
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

More information
GERMANY

Mecklenburg-Vorpommern
ROSTOCK

Accreditation Diagnosis of chronic myeloproliferative disorders
Diagenom GmbH
Purpose(s) : Somatic genetics
Specialty(ies) : Cytogenetics
Objective(s) : Detection of chromosome alterations large in size
Technique(s) : FISH

More information
FRANCE

ILE-DE-FRANCE
SAINT-OUEN-L'AUMÔNE

Accreditation Diagnosis of myeloproliferative syndromes (V617F mutation in JAK2 gene)
Laboratoire Cerba
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing

More information
GERMANY

Hamburg
HAMBURG

Accreditation Diagnosis of chronic myeloproliferative disorders (JAK2 gene: V617F)
Labor Lademannbogen
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

More information
UNITED KINGDOM

Devon
EXETER

Accreditation Molecular diagnosis of myeloproliferative disorders (JAK2 gene)
Royal Devon and Exeter Hospital - Wonford site
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

More information
FRANCE

GRAND-EST
COLMAR

Accreditation Diagnosis of myeloproliferative syndromes (JAK2 gene : V617F mutation)
Hôpital Pasteur - Hôpitaux civils de Colmar
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

OCCITANIE
NÎMES

Accreditation Diagnosis of chronic myeloproliferative disorders (JAK2 gene: V617F)
CHU de Nîmes - Hôpital Carémeau
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

More information
FRANCE

ILE-DE-FRANCE
SAINT-MANDÉ

Accreditation Diagnosis of chronic myeloproliferative disorders (JAK2 gene)
Hôpital d'Instruction des Armées Bégin
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

More information
UNITED KINGDOM

Avon
BRISTOL

Accreditation Molecular haemato-oncology diagnosis of myeloproliferative syndromes (JAK2 gene: V617F mutation and exon 12 analysis)
Southmead Hospital
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

GRAND-EST
METZ

Accreditation Diagnosis of myeloproliferative diseases (JAK gene: V617F mutation)
CHR de Metz-Thionville
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : Sanger sequencing

More information
FRANCE

GRAND-EST
METZ

Accreditation FISH diagnosis of hemopathies
CHR de Metz-Thionville
Purpose(s) : Somatic genetics
Specialty(ies) : Cytogenetics
Objective(s) : Detection of chromosome alterations large in size
Technique(s) : FISH

More information
GERMANY

Sachsen
DRESDEN

Accreditation Diagnosis of chronic myeloproliferative disorders (JAK2 gene)
MVZ Mitteldeutscher Praxisverbund Humangenetik GmbH
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
FRANCE

HAUTS-DE-FRANCE
AMIENS

Accreditation Diagnosis of myeloproliferative disorders (JAK2 gene)
CHU Amiens-Picardie - Site Sud
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
SWEDEN

Region Östergötland
LINKÖPING

Accreditation Molecular diagnosis of myeloproliferative disorders (JAK2 gene)
Universitetssjukhuset i Linköping
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

More information
GERMANY

Bayern
MARTINSRIED

Accreditation Diagnosis of chronic myeloproliferative disorders (translocations: t(3q26) [EVI1] deletions: 4q24 [TET2], 5q31 [EGR1] / 5q33-q34 [CSF1R], 7q22.1/7q31 [RELN/TES], 17p13 [TP53], 20q12 [MYBL2] numeric: -7 [RELN/TES], +8 [cen8], -Y [cen Y])
Zentrum für Humangenetik und Laboratoriumsdiagnostik (MVZ)
Purpose(s) : Somatic genetics
Specialty(ies) : Cytogenetics
Objective(s) : Detection of chromosome alterations large in size
Technique(s) : FISH

More information
SWITZERLAND

Suisse Romande
SION

Accreditation Diagnosis of variants associated with myeloproliferative syndromes (panel)
Institut Central des Hôpitaux (ICH)
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES)

More information
UNITED KINGDOM

West Midlands
BIRMINGHAM

Accreditation Molecular diagnosis of myeloproliferative disorders (JAK2 gene: V617 mutation)
Birmingham Women's NHS Foundation Trust
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

More information
UNITED KINGDOM

Avon
BRISTOL

Accreditation Molecular diagnosis of Chronic myeloproliferative disease (MPL gene)
Southmead Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
UNITED KINGDOM

Wiltshire
SALISBURY

Accreditation Molecular diagnosis of Myeloproliferative disorders (JAK2 gene:mutation V617F: ARMSPCR and pyrosequencing, 9q24)
Salisbury District Hospital
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Technique(s) : PCR based techniques

More information
GERMANY

Bayern
MARTINSRIED

Accreditation Diagnosis of myeloproliferative disorders (translocations: t(9;22) [BCR/ABL1], t(5q31-q33) [PDGFRB], deletions: 4q24 [TET2], 20q12 [MYBL2] numeric: +8 [cen8]
Zentrum für Humangenetik und Laboratoriumsdiagnostik (MVZ)
Purpose(s) : Somatic genetics
Specialty(ies) : Cytogenetics
Objective(s) : Detection of chromosome alterations large in size
Technique(s) : FISH

More information
GERMANY

Bayern
MARTINSRIED

Accreditation Diagnosis of chronic myeloproliferative disorders (TET2 gene (exon 3-11), JAK2 gene (V617F), TP53 (exon 4-9))
Zentrum für Humangenetik und Laboratoriumsdiagnostik (MVZ)
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : Sanger sequencing

More information
GERMANY

Baden-Württemberg
TÜBINGEN

Accreditation Diagnosis of chronic myeloproliferative disorders (JAK2 gene)
CeGaT GmbH
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
AUSTRIA

WIEN
WIEN

Accreditation Molecular diagnosis of myeloproliferative syndromes (JAK2 gene: V617F mutation, sequencing of exon 12; CALR gene exon 9)
Medizinische Universität Wien
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : Sanger sequencing, PCR based techniques

More information
FRANCE

CENTRE-VAL DE LOIRE
CHAMBRAY-LES-TOURS

Accreditation Diagnosis of myeloproliferative disorders (JAK2 gene)
SELAS Arnaud-Biolys-Origet
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

More information
GERMANY

Hamburg
HAMBURG

Accreditation Diagnosis of chronic myeloproliferative disorders (JAK2 gene)
MVZ Fenner & Krasemann
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
FRANCE

BOURGOGNE-FRANCHE-COMTE
BESANÇON

Accreditation Diagnosis of malignant hemopathies
CHRU de Besançon - Hôpital Jean Minjoz
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Cytogenetics

More information
UNITED KINGDOM

Cambridgeshire
CAMBRIDGE

Accreditation Molecular and molecular cytogenetic diagnosis of Myeloproliferative neoplasm (BCR/ABL1, JAK2 (V617F and exon 12 mut), MPL (S505 and W515 mut), FIP1L1/PDGFRA
Cambridge University Hospitals NHS Foundation Trust
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics, Cytogenetics

More information
ITALY

VENETO
PADOVA

Accreditation Molecular diagnosis of myeloproliferative diseases (JAK2 gene)
Azienda Ospedaliera di Padova
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

More information
BELGIUM

LIEGE
LIEGE

Accreditation Molecular diagnosis of essential thrombocythemia and primary myelofibrosis (CALR gene)
CHU de Liège - UniLab Lg
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), PCR based techniques

More information
UNITED KINGDOM

Cambridgeshire
CAMBRIDGE

Accreditation KIT (D816V): Molecular diagnosis of Chronic Myeloid Leukaemia (BCR/ABL1: by PCR, RT-PCR and FISH)
Cambridge University Hospitals NHS Foundation Trust
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics, Cytogenetics
Technique(s) : PCR based techniques, FISH

More information
CANADA

Ontario
MISSISSAUGA

Accreditation Molecular Diagnosis of Myeloproliferative Disorder
Trillium Health Partners- Credit Valley Site
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
SWITZERLAND

Suisse Romande
GENÈVE

Accreditation Conventional (karyotype) and molecular cytogenetics (FISH) diagnosis of myeloproliferative neoplasm: diagnosis and prognosis
Hôpitaux Universitaires de Genève HUG
Purpose(s) : Somatic genetics
Specialty(ies) : Cytogenetics
Objective(s) : Detection of chromosome alterations large in size
Technique(s) : Karyotyping

More information
SPAIN

Cataluña
L'HOSPITALET DE LLOBREGAT

Accreditation Diagnosis of myeloproliferative neoplasm (gene panel)
Reference Laboratory Genetics
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing

More information
FRANCE

ILE-DE-FRANCE
PARIS

Accreditation Diagnosis of aplastic anemia (Panel)
CHU Paris Nord-Val de Seine - Hôpital Xavier Bichat-Claude Bernard
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES)

More information
FRANCE

PAYS DE LA LOIRE
NANTES

Accreditation Diagnosis of polycythemia (Panel)
CHU de Nantes - Institut de Biologie
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing

More information
FRANCE

ILE-DE-FRANCE
PARIS

Accreditation Diagnosis of thrombopathies (Panel)
CHU Paris - Hôpital Robert Debré
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis, Pre-symptomatic diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing

More information
CANADA

Ontario
MISSISSAUGA

Accreditation Molecular Cytogenetic Solid Tumor Analysis (Paraffin Embedded Tissue ALK, MYC, ERBB2)
Trillium Health Partners- Credit Valley Site
Purpose(s) : Somatic genetics
Specialty(ies) : Cytogenetics
Objective(s) : Detection of chromosome alterations large in size
Technique(s) : FISH

More information
AUSTRIA

OBERÖSTERREICH
LINZ

Accreditation Molecular diagnosis of myoproliferative neoplasms (JAK2, CALR, MPL, CSF3R, and SETBP1 genes)
Ordensklinikum Linz GmbH Barmherzige Schwestern
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : Sanger sequencing

More information
SPAIN

Cataluña
L'HOSPITALET DE LLOBREGAT

Accreditation Diagnosis of aplastic anemia and related disorders (gene panel)
Reference Laboratory Genetics
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
GERMANY

Bayern
MÜNCHEN

Accreditation Diagnosis of primary myelofibrosis (JAK2 gene)
Pränatal-Medizin München MVZ GmbH
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
FRANCE

GRAND-EST
VANDOEUVRE-LÈS-NANCY

Accreditation Diagnosis of myeloproliferative syndromes (V617F mutation in JAK2,CALR and MPL genes)
CHU de Nancy - Hôpitaux de Brabois
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

GRAND-EST
VANDOEUVRE-LÈS-NANCY

Accreditation Diagnosis of malignant hemopathies
CHU de Nancy - Hôpitaux de Brabois
Purpose(s) : Somatic genetics
Specialty(ies) : Cytogenetics
Objective(s) : Detection of chromosome alterations large in size
Technique(s) : Karyotyping

More information
GERMANY

Baden-Württemberg
TÜBINGEN

Accreditation Molecular analysis of somatic mutation in tumour tissue for therapeutic decisions (Somatic Tumor Panel, 710 genes)
CeGaT GmbH
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
GERMANY

Baden-Württemberg
TÜBINGEN

Accreditation Diagnosis of hematopoietic defects (NGS screening panel: 183 genes)
CeGaT GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Cataluña
L'HOSPITALET DE LLOBREGAT

Accreditation Diagnosis of primary myelofibrosis
Reference Laboratory Genetics
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Cytogenetics
Objective(s) : Detection of chromosome alterations large in size
Technique(s) : FISH

More information
FRANCE

NORMANDIE
ROUEN

Accreditation Diagnosis of rare genetic tumor (Phenotyping in oncogenetics) (Whole exome)
CHU de Rouen
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Whole Exome Sequencing (WES)

More information
FRANCE

GRAND-EST
VANDOEUVRE-LÈS-NANCY

Accreditation Diagnosis of myeloid hemopathy (Panel)
CHU de Nancy - Hôpitaux de Brabois
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
BELGIUM

LIEGE
LIEGE

Accreditation Diagnosis of chronic myeloproliferative disorders (JAK2 gene: V617F mutation in exon 14)
CHU de Liège - UniLab Lg
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
GERMANY

Baden-Württemberg
ULM

Accreditation Diagnosis of chronic myeloproliferative disorders (JAK2 gene)
DRK Baden-Württemberg/ Hessen
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
CANADA

Ontario
TORONTO

Accreditation Molecular Diagnosis of Myeloproliferative Disorder (JAK2 V617F, CALR targeted mutation analysis)
Toronto General Hospital
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
CANADA

Terre-Neuve-et-Labrador
ST. JOHN'S

Accreditation Molecular Diagnosis of Myeloproliferative Disorder (JAK2 V617F mutation analysis)
Health Sciences Centre
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
CANADA

Ontario
LONDON

Accreditation Molecular Diagnosis of Myeloproliferative Disorder (JAK2 V617F targeted mutation analysis)
London Health Sciences Centre
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
CANADA

Ontario
HAMILTON

Accreditation Molecular Diagnosis of Myeloproliferative Neoplams (JAK2 exon 12, V617F, MPL515 targeted mutation)
McMaster University Medical Centre
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

More information
FRANCE

OCCITANIE
TOULOUSE

Accreditation Diagnosis of myeloproliferative syndromes (V617F mutation in JAK2 gene)
IUCT Oncopole - CHU Toulouse
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
GREECE

THESSALONIKI
THESSALONIKI

Molecular cytogenetics diagnosis of myeloproliferative diseases
Theagenion Cancer Centre of Thessaloniki
Purpose(s) : Somatic genetics
Specialty(ies) : Cytogenetics

More information
TURKEY

TURKEY
ISTANBUL

Molecular diagnosis of myeloproliferative disorder with oesinophilia (PDGFRB gene)
Genetiks - Genetic diagnosis and research center
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

More information
FRANCE

ILE-DE-FRANCE
CRÉTEIL

Diagnosis of myeloproliferative syndromes (JAK2 gene : V617F mutation ; TET2)
Hôpitaux Universitaires Henri Mondor
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : Sanger sequencing

More information
TURKEY

TURKEY
ISTANBUL

Molecular diagnosis of chronic myeloproliferative syndromes (JAK2 gene)
Genetiks - Genetic diagnosis and research center
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

More information
GERMANY

Mecklenburg-Vorpommern
ROSTOCK

Diagnosis of chronic myeloproliferative disorders (JAK2 gene: sequencing / MLPA)
Centogene AG
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
UNITED KINGDOM

Greater Manchester
MANCHESTER

Cytogenetic diagnosis of Myelofibrosis (by full karyotype analysis)
Christie Hospital
Purpose(s) : Somatic genetics
Specialty(ies) : Cytogenetics
Objective(s) : Detection of chromosome alterations large in size
Technique(s) : Karyotyping

More information
SPAIN

País Vasco
SAN SEBASTIÁN

Diagnosis of myelofibrosis with myeloid metaplasia (JAK2 gene / mutation V617F/G1849T)
Hospital Universitario Donostia
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
ITALY

LOMBARDIA
MILANO

Molecular cytogenetic and cytogenetic diagnosis of myeloproliferative neoplasias
Azienda Ospedaliera "San Paolo" - Università degli Studi di Milano
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Cytogenetics
Objective(s) : Detection of chromosome alterations large in size
Technique(s) : Karyotyping

More information
GERMANY

Nordrhein-Westfalen
KÖLN

Diagnosis of myelofibrosis (t(9;22) : bcr (22q11.2), abl (9q34), Chr. 7: CEP7 (7p11.1-q11.1)/ D7S486 (7q31), CEP8 (8p11.1-q11.1), Chr. 13 : D13S319 (13q14.3)/ 13q34, D20S108 (20q12))
Zotz|Klimas Standort Köln
Purpose(s) : Somatic genetics
Specialty(ies) : Cytogenetics

More information
POLAND

Bydgoszcz
BYDGOSZCZ

Molecular diagnosis of myeloproliferative syndromes (V617F mutation in JAK2 gene)
Szpital Uniwersytecki im. dr. Antoniego Jurasza
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

More information
SPAIN

Comunidad Valenciana
PATERNA

Diagnosis of myeloproliferative disorders (MPL gene)
IMEGEN - Delegación Valencia
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES), Sanger sequencing

More information
FRANCE

GRAND-EST
STRASBOURG

Diagnosis of myeloid hemopathies (classical caryotype and FISH)
CHU de Strasbourg - Hôpital de Hautepierre
Purpose(s) : Somatic genetics
Specialty(ies) : Cytogenetics
Technique(s) : FISH

More information
FRANCE

OCCITANIE
TOULOUSE

Diagnosis of myeloid hemopathies
IUCT Oncopole - CLCC Institut Claudius Regaud
Purpose(s) : Somatic genetics
Specialty(ies) : Cytogenetics
Objective(s) : Detection of chromosome alterations large in size
Technique(s) : FISH, Karyotyping

More information
GERMANY

Baden-Württemberg
STUTTGART

Diagnosis of chronic myeloproliferative disorders (JAK2 gene)
Klinikum Stuttgart - Standort Olgahospital
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
ITALY

SICILIA
AVOLA

Diagnosis of myelofibrosis with myeloid metaplasia (JAK2 gene)
Laboratori Campisi s.r.l.
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
SPAIN

Cataluña
TARRAGONA

Diagnosis of myelofibrosis with myeloid metaplasia (JAK2 gene / mutation V617F; CALR gene / mutations in exon 9)
Hospital Universitari de Tarragona Joan XXIII
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
ITALY

BASILICATA
MATERA

Postnatal molecular diagnosis of myeloproliferative syndromes (V617F mutation in JAK2 gene)
Presidio Ospedaliero "Madonna delle Grazie" - Azienda Sanitaria di Matera (ASM)
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
ITALY

LOMBARDIA
VARESE

Molecular diagnosis of primary myelofibrosis (CALR gene)
A.O.U. Ospedale di Circolo e Fondazione Macchi - Università dell'Insubria
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES)

More information
ITALY

LOMBARDIA
VARESE

Molecular diagnosis of myeloproliferative neoplasm (JAK2 gene)
A.O.U. Ospedale di Circolo e Fondazione Macchi - Università dell'Insubria
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : NGS sequencing (except WES)

More information
AUSTRIA

WIEN
WIEN

Molecular cytogenetic diagnosis of myeloproliferative neoplasms (t(9;22)(q34;q11); BCR-ABL amplification, +8, +9, +21, -5/5q-, -7/7q-, 20q-, 13q-, 12p-, i(17q), CHIC2-deletion (FIP1L1/PDGFRa rearrangement), rearrangements of PDGFRa, -b, FGFR1; further analyses upon request)
Labordiagnostik GmbH
Purpose(s) : Somatic genetics
Specialty(ies) : Cytogenetics
Objective(s) : Detection of chromosome alterations large in size, Detection of microdeletions/microduplications
Technique(s) : M-FISH/SKY, FISH

More information
ITALY

LOMBARDIA
SAN FERMO DELLA BATTAGLIA

Molecular diagnosis of primary myelofibrosis (CALR and JAK2 genes)
ASST Lariana - Ospedale S.Anna di Como
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
AUSTRIA

WIEN
WIEN

Molecular diagnosis of chronic myeloproliferative disorders (JAK2 gene)
Medizinische Universität Wien
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
SPAIN

La Rioja
LOGROÑO

Diagnosis of myeloproliferative neoplasm (CALR, JAK2 (exon 12), MPL genes)
Hospital San Pedro
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : Sanger sequencing, PCR based techniques

More information
SPAIN

Madrid
SAN SEBASTIÁN DE LOS REYES

Diagnosis of primary myelofibrosis (JAK2 gene)
LabGenetics - Laboratorio de Genética Clínica, S.L.
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
SPAIN

Cataluña
BARCELONA

Diagnosis of myeloproliferative neoplasm
Hospital de la Santa Creu i Sant Pau
Purpose(s) : Somatic genetics
Specialty(ies) : Cytogenetics
Objective(s) : Detection of chromosome alterations large in size
Technique(s) : Karyotyping

More information
SPAIN

Cataluña
BADALONA

Diagnosis of myeloproliferative neoplasm
ICO Badalona - Hospital Germans Trias i Pujol
Purpose(s) : Somatic genetics
Specialty(ies) : Cytogenetics
Objective(s) : Detection of chromosome alterations large in size
Technique(s) : Karyotyping

More information
AUSTRIA

WIEN
WIEN

Diagnosis of myeloproliferative neoplasms (analysis block: ASXL1, CALR, CBL, CSF3R, EZH2, IDH1, IDH2, JAK2, MPL, SETBP1, SF3B1, SRSF2 gene; single gene analyses: CALR, JAK2 V617F mutation)
Hanusch Krankenhaus
Purpose(s) : Post-natal diagnosis, Somatic genetics, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Comunidad Valenciana
VALENCIA

Diagnosis of solid tumors (panel)
INCLIVA - Facultad de Medicina de la Universidad de Valencia
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : NGS sequencing (except WES)

More information
CZECH REPUBLIC

South Moravia
BRNO

Molecular diagnosis of myeloproliferative neoplasms (JAK2 gene)
University hospital Brno
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

More information
UNITED KINGDOM

Greater Manchester
MANCHESTER

Molecular diagnosis of Polycythaemia Vera, Essential Thrombocythaemia and Idiopathic Myelofibrosis by JAK2 analysis
Manchester University NHS Foundation Trust - Manchester Royal Infirmary
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

More information
ITALY

PUGLIA
SAN GIOVANNI ROTONDO

Molecular diagnosis of myelofibrosis with myeloid metaplasia (JAK2 gene)
IRCCS Ospedale Casa Sollievo della Sofferenza -Poliamb. Giovanni Paolo II
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

More information
ITALY

CALABRIA
REGGIO CALABRIA

Molecular diagnosis of myelofibrosis with myeloid metaplasia (JAK2 gene)
Azienda Ospedaliera BMM
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

More information
LEBANON

Beyrouth
BEIRUT

Molecular diagnosis of myeloproliferative syndromes (V617F mutation of JAK2 gene)
Université Saint-Joseph
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

More information
ROMANIA

CLUJ
CLUJ-NAPOCA

Molecular diagnosis of chronic myeloproliferative diseases (V617F mutation of JAK2 gene)
Spitalul Judetean Clinc de Urgenta Cluj
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

More information
SLOVENIA

SLOVENIA
LJUBLJANA

Molecular diagnosis of chronic myeloproliferative disorders (JAK2 gene: V617F mutation)
University Medical Center Ljubljana
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

More information
SERBIA

Serbia
BELGRADE

Molecular diagnosis of chronic myeloproliferative disorders (JAK2 gene: mutation V617F)
Institute of Molecular Genetics and Genetic Engineering
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

More information
FRANCE

PROVENCE-ALPES-COTE D'AZUR
NICE

Diagnosis of myeloproliferative syndromes (JAK2 gene: V617F mutation)
CHU de Nice - Hôpital Pasteur
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

More information
ITALY

LOMBARDIA
BRESCIA

Molecular diagnosis of myeloproliferative diseases (JAK2 gene)
Biodiversity
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

More information
LITHUANIA

DZUKIJA
VILNIUS

Molecular diagnosis of myeloproliferative disorders (JAK2 gene:mutation V617F)
Vilnius University Hospital Santariskiu Klinikos
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

More information
CZECH REPUBLIC

Olomouc
OLOMOUC

Molecular diagnosis of myeloproliferative disorders (JAK2 gene)
University hospital Olomouc
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

More information
CZECH REPUBLIC

South Bohemia
CESKE BUDEJOVICE

Molecular diagnosis of myeloproliferative disorders (JAK2 gene)
Hospital Ceské Budejovice
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

More information
PORTUGAL

NORTE
PORTO

Molecular cytogenetic diagnosis of malignant haemopathies
Instituto Português de Oncologia do Porto, EPE / IPOFG - CRO Porto
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

More information
PORTUGAL

CENTRO
COIMBRA

Molecular diagnosis of Polycythaemia Vera, Essential Thrombocythaemia and Idiopathic Myelofibrosis (JAK2 gene): V617F mutation and exon 14 quantification (RT-PCR).
Hosp. Pediátrico e Hosp. Covões - Centro Hospitalar e Universitário de Coimbra
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Technique(s) : PCR based techniques

More information
POLAND

Warszawa
WARSAW

Molecular diagnosis of myeloproliferative syndromes (V617F mutation in JAK2 gene)
IHIT Instytut Hematologii I Transfuzjologii
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

More information
SPAIN

Galicia
A CORUÑA

Diagnosis of chronic myeloproliferative disorders (ABL1, BCR, JAK2 genes)
Hospital Universitario da Coruña
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics, Cytogenetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Detection of chromosome alterations large in size
Technique(s) : PCR based techniques, Karyotyping

More information
FRANCE

BRETAGNE
RENNES

Diagnosis of myeloproliferative neoplasm (JAK2 gene by PCR, QPCR)
CHU de Rennes - Hôpital Pontchaillou
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Technique(s) : PCR based techniques

More information
FRANCE

NOUVELLE AQUITAINE
PESSAC

Diagnosis of chronic myeloproliferative disorders (V617F detection and exon 12 sequencing of JAK2 gene)
CHU de Bordeaux-GH Sud - Hôpital Haut-Lévêque
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : Sanger sequencing, PCR based techniques

More information
MOROCCO

Rabat
RABAT

Molecular diagnosis of myeloproliferative syndromes (V617F mutation in JAK2 gene)
Institut National d'Hygiène
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

More information
MOROCCO

Rabat
RABAT

Molecular diagnosis of myelofibrosis with myeloid metaplasia, essential thrombocythemia (Exon 9 of CALR gene)
Institut National d'Hygiène
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
GERMANY

Berlin
BERLIN

Diagnosis of chronic myeloproliferative disorders (JAK2 gene: V617F)
IFLb Laboratoriumsmedizin Berlin GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
SPAIN

Cataluña
BADALONA

Diagnosis of primary myelofibrosis (CALR gene / exon 9; MPL gene / exon 10; JAK2 gene / V617F mutation)
ICO Badalona - Hospital Germans Trias i Pujol
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : Sanger sequencing, PCR based techniques

More information
SPAIN

Cataluña
BADALONA

Diagnosis of myeloid hemopathy (panel)
ICO Badalona - Hospital Germans Trias i Pujol
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Madrid
MADRID

Diagnosis of myeloproliferative neoplasm (JAK2 gene / V617F, exon 12; CALR gene; MPL gene / W515 W505)
Hospital General Universitario Gregorio Marañón
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : Sanger sequencing, PCR based techniques

More information
SPAIN

Madrid
MADRID

Diagnosis of myeloid hemopathy (panel)
Hospital General Universitario Gregorio Marañón
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Asturias
OVIEDO

Diagnosis of primary myelofibrosis
Hospital Universitario Central de Asturias
Purpose(s) : Somatic genetics
Specialty(ies) : Cytogenetics
Objective(s) : Detection of chromosome alterations large in size
Technique(s) : Karyotyping

More information
SPAIN

Asturias
OVIEDO

Diagnosis of myeloproliferative neoplasm
Hospital Universitario Central de Asturias
Purpose(s) : Somatic genetics
Specialty(ies) : Cytogenetics
Objective(s) : Detection of chromosome alterations large in size
Technique(s) : FISH

More information